Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market
Holding DNA?
Track your performance easily

Ginkgo Bioworks Holdings (DNA) Financial Statements

2,085 Followers

Ginkgo Bioworks Holdings Financial Overview

Ginkgo Bioworks Holdings's market cap is currently ―. The company's EPS TTM is $-18.033; its P/E ratio is -0.44; Ginkgo Bioworks Holdings is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 56.21M$ 37.94M$ 34.76M$ 55.43M$ 80.57M
Gross Profit$ 42.48M$ 28.74M$ 31.08M$ 49.41M$ 62.47M
EBIT$ -216.99M$ -177.59M$ -167.88M$ -317.93M$ -187.60M
EBITDA$ -192.23M$ -159.09M$ -150.32M$ -272.81M$ -169.38M
Net Income Common Stockholders$ -227.49M$ -165.91M$ -211.69M$ -302.89M$ -173.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 730.37M$ 840.44M$ 944.07M$ 1.05B$ 1.11B
Total Assets$ 1.63B$ 1.58B$ 1.67B$ 2.03B$ 2.29B
Total Debt$ 452.26M$ 234.50M$ 221.84M$ 403.66M$ 410.94M
Net Debt$ -278.10M$ -605.94M$ -722.24M$ -645.58M$ -694.85M
Total Liabilities$ 792.18M$ 594.49M$ 568.19M$ 773.71M$ 774.27M
Stockholders Equity$ 833.07M$ 987.27M$ 1.10B$ 1.26B$ 1.52B
Cash Flow-
Free Cash Flow$ -111.23M$ -95.97M$ -59.85M$ -77.86M$ -84.76M
Operating Cash Flow$ -84.39M$ -89.26M$ -57.83M$ -73.55M$ -73.53M
Investing Cash Flow$ -26.84M$ -12.11M$ -46.67M$ -3.38M$ -11.22M
Financing Cash Flow$ -226.00K$ -845.00K$ -632.00K$ -315.00K$ -1.38M
Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Ginkgo Bioworks Holdings Debt to Assets

Ginkgo Bioworks Holdings Cash Flow

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis